Related Experiment Video

Updated: Oct 9, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Spanish Menopause Society position statement: Use of denosumab in postmenopausal women

Antonio Cano1, José Manuel Silvan2, Antonio Estévez3

  • 1Hospital Universitario Dr Peset, University of Valencia, Valencia, Spain.

Maturitas
|July 22, 2014
PubMed

Insights

Denosumab effectively manages bone loss in osteoporosis and cancer-related conditions. This expert panel developed recommendations for its use, particularly for postmenopausal women undergoing cancer treatment.

Area of Science:

  • Oncology
  • Endocrinology
  • Bone Metabolism

Background:

  • Denosumab is a novel therapeutic agent.
  • Emerging evidence suggests denosumab's utility in oncological applications.
  • Its role in managing bone loss during cancer therapy is gaining attention.

Purpose of the Study:

  • To provide expert recommendations for denosumab usage.
  • To address the application of denosumab in postmenopausal women's health.
  • To consolidate evidence regarding denosumab's efficacy in cancer-related bone conditions.

Main Methods:

  • Expert panel convened by the Spanish Menopause Society.
  • Review of current scientific literature and clinical evidence.
  • Development of evidence-based usage guidelines.

Main Results:

  • Denosumab demonstrates efficacy in controlling chemotherapy-induced bone loss.
  • Evidence supports denosumab's role in managing hypogonadic states.
  • Potential benefits in reducing cancer metastasis progression are noted.

Conclusions:

  • Denosumab is a valuable option for osteoporosis management.
  • Recommendations focus on its application in cancer patients, especially postmenopausal women.
  • Further research may elucidate broader applications in oncology and bone health.
Keywords:
Breast cancerDenosumabPostmenopausal osteoporosis

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice07:20

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...